Bioxodes meets first Phase 2a patient enrollment milestone
First-in-class drug candidate evaluated in first eight patients Gosselies (Belgium), June 27, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing ...
Read moreFirst-in-class drug candidate evaluated in first eight patients Gosselies (Belgium), June 27, 2024 – Bioxodes SA, a clinical stage biopharmaceutical company developing ...
Read moreElegance met artistry at Four Seasons Hotel Bengaluru, in an evening epitomised by luxury and sophistication. For one night ...
Read moreATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet ...
Read moreNovartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance thresholdSettlement of the ...
Read more30 month median overall survival (OS); median OS independent of patient CPS score ORR 34% (CPS≥1); 48% (CPS≥20) Phase 3 ...
Read moreInstallation view, More than Meets the Eye, February 9 – April 27, 2024, AlUla, Courtesy of The Royal Commission for ...
Read moreHUNTINGTON BEACH, Calif., Jan. 17, 2024 – The all-new CBX 4 ZipCore Wedges from CLEVELAND GOLF® are designed to help ...
Read moreNicosia, Cyprus, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Chainverge is unifying the isolated elements of decentralized finance into a unified ...
Read moreLeading the charge in South Delhi's luxury real estate market, Ekum Homes stands out with its commitment to excellence ...
Read moreBlueberry Therapeutics Meets Primary and Secondary Endpoints in Phase 2b Trial in Onychomycosis Primary endpoint (negative culture and/or clear nail ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.